Free tool
Device Trial Radar
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 19, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching device trials
1,889
Recruiting, industry sponsors
By trial status
The same filters, counted in each status. Pick one to switch.
- Recruiting1,889
- Completed12,323
1,889 trials
Showing 1 to 25, recently updated first.
- Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart FailurePivotal-lookingRecruiting
CVRx, Inc.Not on our public-company list
NCT07232030 · 2,500 participants (planned) · Start Apr 24, 2026 · Primary completion Jan 2033
Device: Barostim System · For: Heart Failure; Heart Failure NYHA Class II; Heart Failure NYHA Class III
Sites: Mobile, Alabama; Los Angeles, California; Clearwater, Florida · 26 sites in all
SynchroHealth LLCNot on our public-company list
NCT07421648 · 39 participants (planned) · Start Mar 25, 2026 · Primary completion Dec 2026
Device: BandPass System · For: Sarcopenia; Frailty
Sites: Chapel Hill, North Carolina · 2 sites in all
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsPivotal-lookingRecruiting
Cleerly, Inc.Not on our public-company list
NCT06112418 · 7,500 participants (planned) · Start Mar 6, 2024 · Primary completion Mar 5, 2029
Device: The Cleerly CAD Staging System · For: Diabetes Mellitus, Type 2; PreDiabetes; Metabolic Syndrome
Sites: Chandler, Arizona; Scottsdale, Arizona; Sun City, Arizona · 125 sites in all
Sanmai Technologies PBC dba SanmaiNot on our public-company list
NCT07207122 · 60 participants (planned) · Start Oct 8, 2025 · Primary completion Dec 2026
Device: Gen0Bh Transcranial Focused Ultrasound System (Active); Gen0Bh Transcranial Focused Ultrasound System (Sham) · For: Parkinson Disease
Sites: Tucson, Arizona; Santa Monica, California; Gainesville, Florida · 4 sites in all
- Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb LossRecruiting
Infinite Biomedical TechnologiesNot on our public-company list
NCT05888428 · 16 participants (planned) · Start Feb 2, 2024 · Primary completion Aug 31, 2027
Device: MyoTrain · For: Amputation; Upper Limb
Sites: Grand Rapids, Michigan
- STIMIT Activator 1 IDE StudyPivotal-lookingRecruiting
Stimit AGNot on our public-company list
NCT05883163 · 40 participants (planned) · Start Jan 24, 2024 · Primary completion Jan 2027
Device: Stimit Activator 1 · For: Diaphragm Issues
Sites: New Haven, Connecticut; Boston, Massachusetts; Charlottesville, Virginia · 4 sites in all
Diality Inc.Not on our public-company list
NCT06613568 · 50 participants (planned) · Start Oct 6, 2025 · Primary completion Mar 2027
Device: Moda-flx Hemodialysis System™ · For: End Stage Kidney Disease
Sites: San Dimas, California; New Hyde Park, New York; Knoxville, Tennessee · 6 sites in all
- Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring FracturesRecruiting
SI-BONE, Inc.Public (SIBN)
NCT07530497 · 120 participants (planned) · Start Aug 24, 2026 · Primary completion Feb 2028
Device: iFuse TORQ TNT Implant System · For: Fracture; Pelvic; Insufficiency Fractures; Fragility Fracture and 3 more
Sites: Los Angeles, California; Edina, Minnesota; Rochester, Minnesota · 4 sites in all
Medtronic - MITGPublic (MDT)
NCT07351071 · 137 participants (planned) · Start Dec 30, 2025 · Primary completion Apr 30, 2027
Device: Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system) · For: Colorectal Anastomosis; Left-sided Colon Resection; Anastomotic Leak and 8 more
Sites: New Haven, Connecticut; Tampa, Florida; Marietta, Georgia · 11 sites in all
- Synchronized Diaphragmatic Stimulation in Symptomatic Heart FailurePivotal-lookingRecruiting
VisCardia Inc.Not on our public-company list
NCT06552637 · 270 participants (planned) · Start Jul 8, 2026 · Primary completion Jul 2028
Device: Synchronized Diaphragmatic Stimulation · For: Heart Failure With Reduced Ejection Fraction
Sites: Indianapolis, Indiana; Tulsa, Oklahoma; Philadelphia, Pennsylvania · 7 sites in all
Recross Cardio, Inc.Not on our public-company list
NCT07172464 · 30 participants (planned) · Start Oct 9, 2025 · Primary completion Aug 2027
Device: Recross P3 Occluder (P3O) System · For: PFO; PFO - Patent Foramen Ovale; Cryptogenic Stroke and 2 more
Sites: Los Angeles, California; Gainsville, Florida; Boston, Massachusetts · 4 sites in all
Artoss Inc.Not on our public-company list
NCT06256458 · 200 participants (planned) · Start Dec 1, 2023 · Primary completion Dec 1, 2026
Device: NanoBone® Bone Graft · For: Fractures, Bone
Sites: Madison, Wisconsin
Stryker InstrumentsPublic (SYK)
NCT03072927 · 8,000 participants (planned) · Start Mar 10, 2017 · Primary completion Dec 2026
Device: MILD; Interspinous Process Decompression · For: Lumbar Spinal Stenosis
Sites: Athens, Alabama; Bay Minette, Alabama; Birmingham, Alabama · 2,450 sites in all
Recross Cardio, Inc.Not on our public-company list
NCT07698951 · 15 participants (planned) · Start Jun 17, 2026 · Primary completion Aug 2027
Device: Recross P3 Occluder (P3O) System · For: PFO; PFO - Patent Foramen Ovale; Cryptogenic Stroke and 2 more
Sites: Belgrade, Serbia; Kamenitz, Serbia
Next Life SciencesNot on our public-company list
NCT07361120 · 40 participants (planned) · Start Jan 15, 2026 · Primary completion Dec 2026
Device: Occlusion System · For: Fertility; Fertility, Male; Healthy Male Adults
Sites: Maribyrnong, Australia; St Kilda, Australia; Vancouver, Canada · 4 sites in all
- Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive EpisodesPivotal-lookingRecruiting
ResilienceNot on our public-company list
NCT07087353 · 594 participants (planned) · Start Oct 31, 2025 · Primary completion Jun 1, 2027
Device: Edra PRO · For: Mood Disorder (Depressive Episodes)
Sites: Besançon, France; Grenoble, France; La Roche-sur-Yon, France · 6 sites in all
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)Pivotal-lookingRecruiting
Supira MedicalNot on our public-company list
NCT07296744 · 358 participants (planned) · Start May 11, 2026 · Primary completion Nov 2027
Device: The Supira System; Impella · For: Coronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology and 1 more
Sites: Loma Linda, California; Sacramento, California; Thousand Oaks, California · 27 sites in all
- The Neuralert Stroke Monitor Pilot TrialRecruiting
Neuralert Technologies LLCNot on our public-company list
NCT06368193 · 50 participants (planned) · Start Dec 12, 2024 · Primary completion Nov 14, 2027
Device: Neuralert Monitor · For: Stroke; Surgery
Sites: Philadelphia, Pennsylvania
Jeisys Medical IncNot on our public-company list
NCT07805655 · 60 participants (planned) · Start Sep 15, 2026 · Primary completion Dec 25, 2026
Device: Sequential Radiofrequency Treatment · For: Acne Vulgaris
Sites: Nuevo León, Mexico
- Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric BypassPivotal-lookingRecruiting
Boston Scientific CorporationPublic (BSX)
NCT07015424 · 108 participants (planned) · Start Apr 14, 2026 · Primary completion Jul 2027
Device: TORe with OverStitch · For: Weight Regain; Weight Loss
Sites: Irvine, California; Stanford, California; Jacksonville, Florida · 12 sites in all
Sofwave Medical LTDNot on our public-company list
NCT07723664 · 30 participants (planned) · Start Jul 20, 2026 · Primary completion Jul 15, 2027
Device: SofWave · For: Facial Wrinkles; Jawline Contour; Skin Laxity
Sites: Houston, Texas
- Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With DiabetesPivotal-lookingRecruiting
CAPTEUR PROTECTNot on our public-company list
NCT07018180 · 194 participants (planned) · Start Dec 5, 2025
Device: Use of COVER patchs for continuous glucose monitoring sensor · For: Diabetes
Sites: Bron, France; Corbeil-Essonnes, France; Grenoble, France · 10 sites in all
- Quantitative Refractive Crosslinking in Adults and Presbyopia-Aged Patients in the PhilippinesRecruiting
TECLens, Inc.Not on our public-company list
NCT07208604 · 25 participants (planned) · Start Oct 11, 2025 · Primary completion May 2027
Device: TECLens CXLens Crosslinking System · For: Presbyopia; Refractive Errors; Myopia and 1 more
Sites: Makati City, Philippines
Aether Tech S.L.Not on our public-company list
NCT07938086 · 24 participants (planned) · Start Apr 15, 2026 · Primary completion Dec 20, 2026
Device: EMILY.AI automatic oxygen titration · For: Chronic Obstructive Pulmonary Disease (COPD); Interstitial Lung Diseases; Pulmonary Hypertension and 1 more
Sites: Madrid, Spain
Signum Surgical USA Inc.Not on our public-company list
NCT07021742 · 50 participants (planned) · Start Jun 14, 2025 · Primary completion Feb 2027
Device: BioHealx · For: Fistula-in-ano
Sites: Fort Myers, Florida; Hackensack, New Jersey; New York, New York · 6 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.